Explainable Machine Learning for ETR and Drug Chameleonicity

Explainable machine learning that identifies molecular "hot spots" for chameleonicity can guide rapid chemical design for oral absorption of beyond-rule-of-five (bRo5) drugs. Traditional in silico methods rely on computationally intensive 3D physics-based modeling or classical descriptors that do not fully explain bRo5 drug behavior. To address this, we introduced the EPSA-to-TPSA ratio (ETR) as a high-throughput measure of polarity reduction, generating data for thousands of macrocycles, PROTACs, and other bRo5s. Using this data set, we developed an explainable deep learning model to predict EPSA and locate polarity-reducing "hot spots" that influence chameleonicity. This first-of-its-kind interpretable model in the bRo5 3D domain guides chemical modifications before synthesis, helping chemists optimize physicochemical properties and design complex bRo5 drugs with improved oral bioavailability. Model insights validated by molecular dynamics enable robust, high-throughput predictions of bRo5 chameleonic behavior, building on Lipinski descriptors to establish new frameworks for complex drug design.

Authors

Institutions

Publication Details

Journal
Journal of Medicinal Chemistry
Published
2025-05-14
DOI
https://doi.org/10.1021/acs.jmedchem.5c00536
Citations
3
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
4.51

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Explainable Machine Learning for ETR and Drug Chameleonicity

David A. DeGoey, Edward Price, Mattson Thieme, Yue-Ting Wang et al.
3 citations
Journal of Medicinal Chemistry
Computational Drug Discovery Methods
4.51
article

Explainable Machine Learning for ETR and Drug Chameleonicity

David A. DeGoey, Edward Price, Mattson Thieme, Yue-Ting Wang, Richard S. Hong, J. Cory Kalvass, Philip B. Cox, Alexey Rivkin, Matthieu Dagommer, Abhishek Pandey, Stella Z. Doktor
article en
3 citations

Abstract

Explainable machine learning that identifies molecular "hot spots" for chameleonicity can guide rapid chemical design for oral absorption of beyond-rule-of-five (bRo5) drugs. Traditional in silico methods rely on computationally intensive 3D physics-based modeling or classical descriptors that do not fully explain bRo5 drug behavior. To address this, we introduced the EPSA-to-TPSA ratio (ETR) as a high-throughput measure of polarity reduction, generating data for thousands of macrocycles, PROTACs, and other bRo5s. Using this data set, we developed an explainable deep learning model to predict EPSA and locate polarity-reducing "hot spots" that influence chameleonicity. This first-of-its-kind interpretable model in the bRo5 3D domain guides chemical modifications before synthesis, helping chemists optimize physicochemical properties and design complex bRo5 drugs with improved oral bioavailability. Model insights validated by molecular dynamics enable robust, high-throughput predictions of bRo5 chameleonic behavior, building on Lipinski descriptors to establish new frameworks for complex drug design.

Journal of Medicinal ChemistryVol. 68(15)
AbbVie (United States) (US)
AbbVie
Zero hunger
Openalex Percentile: Top 6%
Computational Drug Discovery Methods
4.51
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.